Third Harmonic Bio, Inc. (THRD) has a consensus analyst rating of Hold, based on 5 analysts covering the stock. Of those, 1 recommend buying, 4 recommend holding, and 0 recommend selling.
The analyst consensus price target for THRD is $16.15, representing a +200.2% upside from the current price of $5.38. Price targets range from a low of $3.60 to a high of $23.00.
